Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Obalon Therapeutics Inc (OBLN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6530
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gastric balloon for weight loss therapy. Obalon Therapeutics’ Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity. The company’s Obalon balloon system is also designed to provide weight loss in obese patients with combined with diet and exercise. It offers its products through its distributors located across the US, Obalon Therapeutics is headquartered in Carlsbad, California, the US.

Obalon Therapeutics Inc (OBLN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Obalon Therapeutics Raises USD20 Million in Series D Financing 10
Obalon Therapeutics Secures USD10 Million from Square 1 Bank 12
Obalon Therapeutics Raises USD16 Million in Venture Financing 13
Obalon Therapeutics Raises US$5 Million In Venture Financing 14
Obalon Therapeutics Raises US$16.5 Million In Series C Financing 15
Obalon Therapeutics Raises US$1.5 Million In Venture Financing 16
Equity Offering 17
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 18
Obalon Therapeutics Terminates Public Offering of Shares for USD30 Million 20
Obalon Therapeutics Prices IPO for USD75 Million 22
Obalon Therapeutics Inc – Key Competitors 24
Obalon Therapeutics Inc – Key Employees 25
Obalon Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Obalon Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Raises USD20 Million in Series D Financing 10
Obalon Therapeutics Secures USD10 Million from Square 1 Bank 12
Obalon Therapeutics Raises USD16 Million in Venture Financing 13
Obalon Therapeutics Raises US$5 Million In Venture Financing 14
Obalon Therapeutics Raises US$16.5 Million In Series C Financing 15
Obalon Therapeutics Raises US$1.5 Million In Venture Financing 16
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 18
Obalon Therapeutics Terminates Public Offering of Shares for USD30 Million 20
Obalon Therapeutics Prices IPO for USD75 Million 22
Obalon Therapeutics Inc, Key Competitors 24
Obalon Therapeutics Inc, Key Employees 25

List of Figures
Obalon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cannabics Pharmaceuticals Inc (CNBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • Discovery Communications, Inc.:企業の戦略・SWOT・財務情報
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Onorach Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Onorach Ltd (Onorach) is a contract research organization that provides clinical support services. The organization service portfolio includes tailored clinical trial support, clinical plan development, protocol design, regulatory, quality management, clinical operations management, patient …
  • Theralase Technologies Inc (TLT):製品パイプライン分析
    Summary Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such as controller, multiple probe, triple probe, single probe, multiple p …
  • Banca Monte dei Paschi di Siena SpA:企業のM&A・事業提携・投資動向
    Banca Monte dei Paschi di Siena SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banca Monte dei Paschi di Siena SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • ABF Ingredients Ltd:企業の戦略・SWOT・財務情報
    ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report Summary ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Power Clean Energy Development Co Ltd (735):電力:M&Aディール及び事業提携情報
    Summary China Power Clean Energy Development Co Ltd (CPCE) formerly China Power New Energy Development Co Ltd, is an electric utility. It develops, constructs, owns, operates, and manages clean energy power plants. The company produces electricity through natural gas, wind, hydro, and solar sources. …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers herbal tea, Chinese and Western medicine, intermed …
  • China International Marine Containers (Group) Co Ltd:企業のM&A・事業提携・投資動向
    China International Marine Containers (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China International Marine Containers (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busines …
  • NxStage Medical Inc (NXTM):企業の製品パイプライン分析2018
    Summary NxStage Medical Inc (NxStage) is a medical technology company that develops, manufactures and markets conventional dialysis machines. The company develops products for the treatment of end-stage renal disease and acute kidney failure. It provides products such as nxstage system one, cartridg …
  • Transgene SA (TNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …
  • GE Lighting LLC:企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sevan Marine ASA (SEVAN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sevan Marine ASA (Sevan Marine) is an oil and gas company that offers engineering, design, and project execution of floating units for offshore applications. The company's floating production units include Hummingbird spirit, Voyageur spirit, Piranema spirit, Goliat FPSO and Western Isles FP …
  • Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報
    Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and f …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野:企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • Laissez-Faire Catering Pty Ltd
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • XOMA Corp (XOMA):企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆